FI916018A7 - 1,3-dioksolaanijohdannaisia kolesterolia alentavina aineina - Google Patents

1,3-dioksolaanijohdannaisia kolesterolia alentavina aineina Download PDF

Info

Publication number
FI916018A7
FI916018A7 FI916018A FI916018A FI916018A7 FI 916018 A7 FI916018 A7 FI 916018A7 FI 916018 A FI916018 A FI 916018A FI 916018 A FI916018 A FI 916018A FI 916018 A7 FI916018 A7 FI 916018A7
Authority
FI
Finland
Prior art keywords
cholesterol
lowering agents
dioxolane derivatives
dioxolane
derivatives
Prior art date
Application number
FI916018A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI916018L (fi
FI916018A0 (fi
Inventor
Keith A M Walker
Pamela M Burton
David C Swinney
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI916018A0 publication Critical patent/FI916018A0/fi
Publication of FI916018A7 publication Critical patent/FI916018A7/fi
Publication of FI916018L publication Critical patent/FI916018L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI916018A 1990-12-20 1991-12-19 1,3-dioxolanderivat som kolesterol- saenkande medel. FI916018L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/633,599 US5158949A (en) 1990-12-20 1990-12-20 1,3-dioxolane derivatives as cholesterol-lowering agents

Publications (3)

Publication Number Publication Date
FI916018A0 FI916018A0 (fi) 1991-12-19
FI916018A7 true FI916018A7 (fi) 1992-06-21
FI916018L FI916018L (fi) 1992-06-21

Family

ID=24540306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI916018A FI916018L (fi) 1990-12-20 1991-12-19 1,3-dioxolanderivat som kolesterol- saenkande medel.

Country Status (21)

Country Link
US (1) US5158949A (enExample)
EP (1) EP0492474B1 (enExample)
JP (1) JPH04308588A (enExample)
KR (1) KR920011484A (enExample)
AT (1) ATE149495T1 (enExample)
AU (1) AU650079B2 (enExample)
CA (1) CA2058068A1 (enExample)
DE (1) DE69124956T2 (enExample)
DK (1) DK0492474T3 (enExample)
FI (1) FI916018L (enExample)
GR (1) GR3022740T3 (enExample)
HU (2) HUT61998A (enExample)
IE (1) IE914442A1 (enExample)
IL (1) IL100430A (enExample)
IT (1) IT1250362B (enExample)
MX (1) MX9102703A (enExample)
NO (1) NO179006C (enExample)
NZ (1) NZ241068A (enExample)
PT (1) PT99859A (enExample)
TW (1) TW230208B (enExample)
ZA (1) ZA9110019B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208331A (en) * 1992-06-18 1993-05-04 Syntex (U.S.A.) Inc. Process for preparing 1,3-dioxolane derivatives
US5274108A (en) * 1992-06-18 1993-12-28 Syntex (U.S.A.) Inc. Process for preparing 1,3-dioxolane derivatives
KR100331609B1 (ko) * 1995-04-21 2002-11-18 성 렬 류 신규한시스-튜불라졸유도체및그의제조방법
KR100704710B1 (ko) * 1999-10-29 2007-04-09 주식회사 중외제약 간 섬유화 억제작용을 나타내는 벤조[3,4-ｄ]1,3-디옥솔란 유도체
WO2008151437A1 (en) 2007-06-14 2008-12-18 Osta Biotechnologies Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
BR112019006451A2 (pt) * 2016-09-29 2019-06-25 Bayer Ag derivados substituídos de 1,5 imidazóis como fungicidas para proteção de plantação.
US11241417B2 (en) 2018-06-21 2022-02-08 Yumanity Therapeutics, Inc. Compositions and methods for the treatment and prevention of neurological disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4321272A (en) * 1980-08-25 1982-03-23 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkylimidazoles
EP0052905B1 (en) * 1980-11-24 1984-10-03 Janssen Pharmaceutica N.V. Novel (2-aryl-4-phenylthioalkyl-1,3-dioxolan-2-yl-methyl)azole derivatives
US4490540A (en) * 1981-09-14 1984-12-25 Janssen Pharmaceutica N.V. (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
US4359475A (en) * 1981-12-21 1982-11-16 Syntex (U.S.A.) Inc. Thioketal substituted N-alkyl imidazoles
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
ES8600261A1 (es) * 1983-06-24 1985-10-01 Yamanouchi Pharma Co Ltd Un compuesto fenoxi
US4518607A (en) * 1983-07-18 1985-05-21 Syntex (U.S.A.) Inc. Male oral contraceptive N-alkylimidazole derivatives, compositions, and method of use therefor
US4940799A (en) * 1987-07-20 1990-07-10 Ciba-Geigy Corporation Preparation of the diastereomeric mixture 2R,4S-1-[2-(2,4-dichlorophenyl)-4-n-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole
AU614818B2 (en) * 1988-03-28 1991-09-12 Janssen Pharmaceutica N.V. 2-imidazolylmethyl-1,3-dioxolanyl methylthiophenyl carbamate derivatives and their use as antineoplastic agents

Also Published As

Publication number Publication date
ATE149495T1 (de) 1997-03-15
IL100430A (en) 1997-03-18
NZ241068A (en) 1996-12-20
ITTO910999A0 (it) 1991-12-19
EP0492474B1 (en) 1997-03-05
MX9102703A (es) 1992-06-01
IE914442A1 (en) 1992-07-01
ZA9110019B (en) 1993-06-21
NO915036L (no) 1992-06-22
FI916018L (fi) 1992-06-21
KR920011484A (ko) 1992-07-24
IT1250362B (it) 1995-04-07
CA2058068A1 (en) 1992-06-21
US5158949A (en) 1992-10-27
AU8990591A (en) 1992-06-25
JPH04308588A (ja) 1992-10-30
NO179006C (no) 1996-07-17
DE69124956T2 (de) 1997-06-12
DK0492474T3 (da) 1997-03-24
DE69124956D1 (de) 1997-04-10
HUT61998A (en) 1993-03-29
PT99859A (pt) 1992-12-31
GR3022740T3 (en) 1997-06-30
NO179006B (no) 1996-04-09
HU914024D0 (en) 1992-03-30
IL100430A0 (en) 1992-09-06
EP0492474A1 (en) 1992-07-01
FI916018A0 (fi) 1991-12-19
TW230208B (enExample) 1994-09-11
HU210718A9 (en) 1995-06-28
AU650079B2 (en) 1994-06-09
ITTO910999A1 (it) 1993-06-19
NO915036D0 (no) 1991-12-19

Similar Documents

Publication Publication Date Title
NO920018L (no) 1,3-oksatiolannukleosidanaloger
FI932402A7 (fi) Foerfarande och anordning foer saendning, mottagning och oeverfoering av datasignaler med motsvarande programdatasignaler
FI925443L (fi) 3-amino-2-arylkinuklidiner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI925767A0 (fi) Dialkoxi-pyridinyl-bensimidazolderivater, foerfaranden foer deras framstaellning och deras farmaceutiska anvaendning
FI930970A7 (fi) Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa
FI931916L (fi) Transdermala befruktningshindrande formuleringar, metoder och anordningar
FI931763L (fi) 4,1-bensoxazepinderivat och deras anvaendning
FI925766A7 (fi) Substituerade bensimidazoler, foerfarande foer deras framstaellning och deras farmaceutiska anvaendning
FI930634L (fi) Benzimidazolderivat, foerfarande foer framstaellning daerav och deras anvaendning
FI931499A0 (fi) Cyklopeptider, foerfarande foer deras framstaellning och deras anvaendningsaosom laekemedel
FI925924L (fi) Hydrerat staerkelsehydrolysat med laog kariesframkallande effekt, foerfarande foer framstaellning av detta och tillaempningen av detta hydrolysat
FI930429A7 (fi) Uusia 1,4-dihydropyridiinijohdannaisia
ATA992A (de) (6,7-substituierte-8-alkoxy-1-cyclopropyl-1,4-
FI922875L (fi) Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning
FI934498A0 (fi) Vikbart foeremaol, saosom informationsbaerare, behaollare och motsvarande
FI930633L (fi) Benzinmidazolderivat, foerfarande foer framstaellning daerav och deras anvaendning
FI930296L (fi) 1,4-disubstituerade piperaziner
FI916018A7 (fi) 1,3-dioksolaanijohdannaisia kolesterolia alentavina aineina
FI932874L (fi) 6,7-modifierade 11b-aryl-4-estrener
FI944655A7 (fi) Uudet 2,3-dihydro-2,2,4,6,7-penta-alkyyli-5-bentsofuranolit
DE69122555D1 (de) 2,4-Dihydroxyadipinsäurederivate
FI930450L (fi) Hoegviskoesa bakterier, bakterieblandningar och foerfaranden
FI925111L (fi) Substituerade 1,5-pentadioler och foerfarande foer deras framstaellning
FI921456L (fi) Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel
FI924756L (fi) 1,5-benzotiazepinonderivat, deras framstaellning och farmaceutiska anvaendning

Legal Events

Date Code Title Description
FD Application lapsed